We constantly seek innovative therapies for unmet medical needs as well as therapies that have the potential to impart a fresh approach to current treatment practices. Of particular interest to Avicenna are therapies that target immune diseases or act via immune pathways. If you believe that you have tomorrow's innovative products and technologies, please get in touch with our scientific team who would be happy to discuss the development strategy.
 
As preliminary information, Avicenna would require a summary information sheet that outlines in brief the product concept, therapy use and key milestones achieved till date.
 
Should Avicenna evince interest in your product, you will be required to provide further detailed technical inputs based on which Avicenna would perform a due-diligence on the product. A successful due-diligence and a mutually beneficial license agreement then paves the way for the product to become part of the Avicenna pipeline.

Avicenna secures development and commercialisation rights from various sources including,

• small biotech and discovery companies that are seeking competent partners to develop their products
• biotech and pharmaceutical companies that have given priority to lead compounds and have little interest in developing 2nd tier compounds
• academia, governmental and non-governmental research organisations and medical charities that have funded discovery research but have no interets or lack the skills in commercial development

To offer your product, please contact us.